Do tirzepatide and semaglutide affect focus and thinking?
The Wegovy (semaglutide), Mounjaro and Zepbound (tirzepatide) labels we read do not list brain fog or memory loss, but they do list tiredness and dizziness. In US trials, 11% of people on Wegovy reported tiredness, against 5% on placebo. We found no trial with focus as its main result in people without dementia, and oral semaglutide did not slow early Alzheimer's disease.
Do the labels list brain fog or memory problems?
No label we read lists brain fog, memory loss or poor concentration as a side effect, but all of them list tiredness and dizziness.123456
In US trials of the Wegovy 2.4 mg injection, 11% of people reported tiredness, against 5% on placebo. Dizziness affected 8%, against 4%.2 In US Zepbound trials, tiredness affected 5% to 7% across doses, against 3% on placebo. The label counts lethargy and malaise as tiredness. Dizziness affected 4% to 5%, against 2%.1
The EU, UK and Canadian semaglutide labels say it has “no or negligible influence” on driving. They add that dizziness happens mainly while the dose is being raised.467 The EU and UK tirzepatide labels say the same about driving.35 The NHS says not to drive, cycle or use machinery while you feel dizzy.89
Can low blood sugar cloud your thinking?
Yes, low blood sugar can, and the EU Wegovy patient leaflet lists feeling confused and difficulty concentrating among its warning signs.4
The NHS says low blood sugar is more likely if you also take other diabetes medicines.8 The EU Mounjaro label reports a weight trial in people with type 2 diabetes. In it, 10.3% of those also taking a sulfonylurea (a diabetes tablet) had low blood sugar. Among those not taking one, it was 2.1%.3
The US Zepbound label says a lower insulin or sulfonylurea dose may reduce this risk. It adds that low blood sugar has also been linked to these medicines in adults without type 2 diabetes.1
Do they sharpen focus or protect the brain?
We found no trial of semaglutide or tirzepatide that tested focus or attention as its main result in people who do not have dementia, after searching on 16 November 2026.
The ClinicalTrials.gov registry lists no registered study of either medicine in ADHD.11 The largest brain trial so far tested oral semaglutide 14 mg in early Alzheimer's disease. In the EVOKE and EVOKE+ trials, 3,808 people aged 55 to 85 took semaglutide or a placebo.10
After 104 weeks, symptoms had progressed by a similar amount in both groups. Adverse events of any kind were reported by 91.2% of people on semaglutide and 84.8% on placebo.10
Can they change mood?
Studies point in different directions, with one US health-records study linking both medicines to fewer depression diagnoses than naltrexone-bupropion and side-effect reports flagging depression with semaglutide.1213
The records study followed US adults for 24 months after they started semaglutide, tirzepatide or another weight medicine. Compared with naltrexone-bupropion, both GLP-1 medicines were linked to fewer new anxiety and depression diagnoses. In people without diabetes, tirzepatide was linked to slightly more anxiety and insomnia than semaglutide.12
A study of US, Canadian and Australian side-effect databases found more US reports than expected of depression, panic attacks and suicidal thoughts with semaglutide.13 Neither kind of study can prove the medicine caused the change.1213 In February 2026, the US Zepbound and Wegovy labels removed their warning section on suicidal thoughts.12
What do people on GLP-1 medicines report about focus and thinking?
From public patient forums: 22 Reddit threads in r/Zepbound, r/Mounjaro, r/Ozempic, r/Semaglutide, r/WegovyWeightLoss and r/mounjarouk, posted from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Not studied Many describe clearer thinking or better focus, and many credit quieter thoughts about food for freeing up attention. We found no trial that measured this.
- Not studied Many describe brain fog, slowed thinking or forgetfulness, from the first days to a year in. We found no study of brain fog on these medicines.
- Matches the label Many link the fog to tiredness or low energy. The US labels list tiredness as a side effect.12
- Not studied Many people with ADHD or ADHD traits say their focus changed, mostly for the better. Several felt wired, or felt their mind went too quiet.
- Matches the label Several describe dizziness or feeling off.12
Advice people share
- Not studied Many advise eating regular meals even when hunger is gone. We found no study linking meal pattern to focus on these medicines.
- Matches the label Several advise reviewing other medicines with the prescriber, including ADHD medicines, antidepressants and insulin. The US Zepbound label says a lower insulin or sulfonylurea dose may reduce low blood sugar.1
- Matches the label Many advise drinking enough fluids. The US Wegovy label also tells patients to avoid fluid loss, to protect the kidneys.2
In your country
The labels we read agree on tiredness, dizziness and low blood sugar, while the brands sold, and the labels we could open, differ by country.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: We did not open Australia’s Product Information for this page. It relies on the US, EU, UK and Canadian labels in the sources.1357
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: Canada’s Wegovy monograph says driving or using machines should be avoided if dizziness occurs, where the EU and UK labels say to take care.746 We did not open Canada’s Mounjaro or Zepbound monographs for this page. It relies on the US, EU and UK tirzepatide labels.135
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The answer above applies.
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies.
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We did not open an Indian label for this page. It relies on the US, EU and UK labels in the sources.135
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a Saudi label for this page. It relies on the US, EU and UK labels in the sources.135
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a UAE label for this page. It relies on the US, EU and UK labels in the sources.135
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies.
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Contact your prescriber or a doctor right away if you have signs of low blood sugar, such as feeling dizzy, weak or confused, a fast heartbeat or sweating, especially if you also take other diabetes medicines.8 Speak to a pharmacist or doctor about any side effect that bothers you or does not go away.8
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information, Eli Lilly, revised August 2026. pi.lilly.com
- US Wegovy (semaglutide) prescribing information, Novo Nordisk, revised June 2026, on DailyMed. dailymed.nlm.nih.gov
- EU Mounjaro (tirzepatide) summary of product characteristics (SmPC), European Medicines Agency. ema.europa.eu
- EU Wegovy (semaglutide) SmPC and package leaflet, European Medicines Agency. ema.europa.eu
- UK Mounjaro KwikPen (tirzepatide) SmPC, emc. medicines.org.uk
- UK Wegovy FlexTouch (semaglutide) SmPC, emc. medicines.org.uk
- Canada Wegovy (semaglutide injection) Product Monograph, Novo Nordisk Canada. pdf.hres.ca
- NHS. Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. nhs.uk
- NHS. Semaglutide: a medicine to manage type 2 diabetes or treat obesity. nhs.uk
- Cummings JL, et al. Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials. Lancet, 2026;407(10544):2167-2179. europepmc.org
- ClinicalTrials.gov. Registry searches for ADHD with semaglutide or tirzepatide, run 16 November 2026 (no studies found). clinicaltrials.gov
- Huang YN, et al. Neuropsychiatric association of tirzepatide and semaglutide in obesity with and without type 2 diabetes. 2026. PMC13683400
- Katranski J, et al. Psychiatric adverse events linked to glucagon-like peptide 1 analogues: a disproportionality analysis in American, Canadian and Australian adverse event databases. 2025. PMC12630159
- American College of Emergency Physicians. Know when to go to the ER. emergencyphysicians.org
Last checked 16 Nov 2026 · Next review due 16 Nov 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on 9 or 16 Nov 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write